WHO ICTRP trial
study to evaluate the clinical benefit of administering clopidogrel loading dose…
EUCTR2011-005095-41-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2011-005095-41-IT |
|---|---|
| Public title | study to evaluate the clinical benefit of administering clopidogrel loading dose prior to the procedure of coronary angioplasty |
| Scientific title | prospective randomized study Armyda Pro 240 - ARMYDA PRO 240 |
| Primary sponsor | UNIVERSITA' CAMPUS BIOMEDICO |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | patients treated with clopidogrel candidates for coronary angioplasty for ST-segment elevation acute coronary syndrome or stable angina MedDRA version: 14.1 Level: SOC Classification code 10007541 Term: Cardiac disorders System Organ Class… |
| Interventions | Trade Name: CLOPIDOGREL WINTH.*50x1CPR 75M Pharmaceutical Form: Film-coated tablet INN or Proposed INN: CLOPIDOGREL SULFATE Concentration unit: mg milligram(s) Concentration type: up to Concentration number: 600- |
| Registration date | Dec 23, 2011 |
| Target size | 300 |
| Secondary IDs | ARMYDAPRO240 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: